289 related articles for article (PubMed ID: 26364057)
21. Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy.
Chen K; Yang D; Li X; Sun B; Song F; Cao W; Brat DJ; Gao Z; Li H; Liang H; Zhao Y; Zheng H; Li M; Buckner J; Patterson SD; Ye X; Reinhard C; Bhathena A; Joshi D; Mischel PS; Croce CM; Wang YM; Raghavakaimal S; Li H; Lu X; Pan Y; Chang H; Ba S; Luo L; Cavenee WK; Zhang W; Hao X
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1107-12. PubMed ID: 25583476
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.
Hovelson DH; McDaniel AS; Cani AK; Johnson B; Rhodes K; Williams PD; Bandla S; Bien G; Choppa P; Hyland F; Gottimukkala R; Liu G; Manivannan M; Schageman J; Ballesteros-Villagrana E; Grasso CS; Quist MJ; Yadati V; Amin A; Siddiqui J; Betz BL; Knudsen KE; Cooney KA; Feng FY; Roh MH; Nelson PS; Liu CJ; Beer DG; Wyngaard P; Chinnaiyan AM; Sadis S; Rhodes DR; Tomlins SA
Neoplasia; 2015 Apr; 17(4):385-99. PubMed ID: 25925381
[TBL] [Abstract][Full Text] [Related]
23. The Relationship Between Gene Mutations and the Clinicopathological Features and Prognosis of Gastric Cancer.
Nie Z; Zeng K; Yan Q; Liu Y; Bian Y; Zhu J; Guo Z; He F; Shi H; Guo Y
Int J Surg Pathol; 2024 May; 32(3):486-495. PubMed ID: 37545327
[TBL] [Abstract][Full Text] [Related]
24. Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing.
Backman S; Norlén O; Eriksson B; Skogseid B; Stålberg P; Crona J
Anticancer Res; 2017 Feb; 37(2):705-712. PubMed ID: 28179320
[TBL] [Abstract][Full Text] [Related]
25. Application of next-generation sequencing in the diagnosis of gastric cancer.
Moradi N; Ohadian Moghadam S; Heidarzadeh S
Scand J Gastroenterol; 2022 Jul; 57(7):842-855. PubMed ID: 35293278
[No Abstract] [Full Text] [Related]
26. Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4.
Hosoda W; Chianchiano P; Griffin JF; Pittman ME; Brosens LA; Noë M; Yu J; Shindo K; Suenaga M; Rezaee N; Yonescu R; Ning Y; Albores-Saavedra J; Yoshizawa N; Harada K; Yoshizawa A; Hanada K; Yonehara S; Shimizu M; Uehara T; Samra JS; Gill AJ; Wolfgang CL; Goggins MG; Hruban RH; Wood LD
J Pathol; 2017 May; 242(1):16-23. PubMed ID: 28188630
[TBL] [Abstract][Full Text] [Related]
27. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
28. Construction of a combinatorial pipeline using two somatic variant calling methods for whole exome sequence data of gastric cancer.
Kohmoto T; Masuda K; Naruto T; Tange S; Shoda K; Hamada J; Saito M; Ichikawa D; Tajima A; Otsuji E; Imoto I
J Med Invest; 2017; 64(3.4):233-240. PubMed ID: 28954988
[TBL] [Abstract][Full Text] [Related]
29. The impact of recent next generation sequencing and the need for a new classification in gastric cancer.
Businello G; Galuppini F; Fassan M
Best Pract Res Clin Gastroenterol; 2021; 50-51():101730. PubMed ID: 33975684
[TBL] [Abstract][Full Text] [Related]
30. Towards the goal of personalized medicine in gastric cancer--time to move beyond HER2 inhibition. Part II: Targeting gene mutations and gene amplifications and the angiogenesis pathway.
Lee J; Ou SH
Discov Med; 2013 Aug; 16(86):7-14. PubMed ID: 23911227
[TBL] [Abstract][Full Text] [Related]
31. Molecular classification of gastric cancer.
Chia NY; Tan P
Ann Oncol; 2016 May; 27(5):763-9. PubMed ID: 26861606
[TBL] [Abstract][Full Text] [Related]
32. FGFR2 alteration as a potential therapeutic target in poorly cohesive gastric carcinoma.
Wang Y; Shi T; Wang X; Hu J; Yu L; Liu Q; Wu N; Liu B; Wei J
J Transl Med; 2021 Sep; 19(1):401. PubMed ID: 34551773
[TBL] [Abstract][Full Text] [Related]
33. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
35. Clinical Applications of Next-Generation Sequencing in Cancer Diagnosis.
Sabour L; Sabour M; Ghorbian S
Pathol Oncol Res; 2017 Apr; 23(2):225-234. PubMed ID: 27722982
[TBL] [Abstract][Full Text] [Related]
36. Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis.
Romano C; Di Gregorio S; Pennisi MS; Tirrò E; Broggi G; Caltabiano R; Manzella L; Ruggieri M; Vigneri P; Di Cataldo A
Mol Biol Rep; 2022 Sep; 49(9):9059-9064. PubMed ID: 35715605
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of ARID1A mutations with mRNA levels and protein expression in gastric carcinoma.
Hwang I; Cho Y; Kang SY; Kim DG; Ahn S; Lee J; Kim KM
Pathol Res Pract; 2024 Mar; 255():155063. PubMed ID: 38324965
[TBL] [Abstract][Full Text] [Related]
38. Novel gene mutations in well-differentiated fetal adenocarcinoma of the lung in the next generation sequencing era.
Fu Y; Wu Q; Su F; Tang Y; Lin Y; Wang W; Jiang L
Lung Cancer; 2018 Oct; 124():1-5. PubMed ID: 30268445
[TBL] [Abstract][Full Text] [Related]
39. Search for new genetic biomarkers in poorly differentiated and anaplastic thyroid carcinomas using next generation sequencing.
Sykorova V; Dvorakova S; Vcelak J; Vaclavikova E; Halkova T; Kodetova D; Lastuvka P; Betka J; Vlcek P; Reboun M; Katra R; Bendlova B
Anticancer Res; 2015 Apr; 35(4):2029-36. PubMed ID: 25862857
[TBL] [Abstract][Full Text] [Related]
40. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer.
Wang K; Yuen ST; Xu J; Lee SP; Yan HH; Shi ST; Siu HC; Deng S; Chu KM; Law S; Chan KH; Chan AS; Tsui WY; Ho SL; Chan AK; Man JL; Foglizzo V; Ng MK; Chan AS; Ching YP; Cheng GH; Xie T; Fernandez J; Li VS; Clevers H; Rejto PA; Mao M; Leung SY
Nat Genet; 2014 Jun; 46(6):573-82. PubMed ID: 24816253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
